Recruiting

Observational Study

Sponsor:

State University of New York at Buffalo

Code:

NCT03025074

Conditions

Non-Alcoholic Steatohepatitis(NASH)

Hepatitis C

Hepatitis B

Fibrosis

Cirrhosis

Eligibility Criteria

Sex: All

Age: 7+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Conditions

Non-Alcoholic Steatohepatitis(NASH)

Hepatitis C

Hepatitis B

Fibrosis

Cirrhosis

Study ID

NCT03025074

Start date

Jul, 2013

Status verified date

Aug, 2025

Completion date

Dec, 2099

Anticipated

Primary completion date

Dec, 2099

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 7+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
  • Children and teenagers will be special populations considered in this protocol.

Exclusion Criteria:

  • Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Number of samples collected [ Time Frame: 52 weeks ]

Central Contacts and Locations

Central contacts

Barbara Bauer, BA

716-888-4825bmbauer@buffalo.edu

Locations

University at Buffalo, Buffalo General Medical Center

Recruiting

Buffalo, New York, United States, 14203

Contacts

Barbara Bauer, BA

716-888-4825bmbauer@buffalo.edu

More Information

Sponsor

State University of New York at Buffalo

Last update posted

Aug 27, 2025

Last verified

Aug, 2025

Keywords

  • Liver Disease
  • Obesity
  • Hepatitis
  • HIV
  • Hepatology

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by State University of New York at Buffalo on 2025-08-27.